Ezra M. Friedberg
Director · Pelthos Therapeutics Inc.
Individual8 10b5-1 trades
- 2024
- Oct 6, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ezra M. Friedberg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd C. Davis - $1000K in PTHS purchases and sales in the last 12 months
- Peter Greenleaf - $54K in PTHS purchases and sales in the last 12 months
- Matthew Pauls - $54K in PTHS purchases and sales in the last 12 months
- Knuettel Francis II - $40K in PTHS purchases and sales in the last 12 months
- Richard Malamut - $12K in PTHS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ezra M. Friedberg?
Ezra M. Friedberg is a corporate insider, tracked as Director of Pelthos Therapeutics Inc. (PTHS). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ezra M. Friedberg submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ezra M. Friedberg been buying or selling stock?
Recorded transactions: 2 open-market purchases and 11 open-market sales ($326K) across all tracked filings.
